Dyne Therapeutics Inc
NASDAQ:DYN
Dyne Therapeutics Inc
NASDAQ:DYN
Price:
18.21
USD
-0.11%
Market Closed
Market Cap:
$2.6B
Balance Sheet
Balance Sheet Decomposition
Dyne Therapeutics Inc
Dyne Therapeutics Inc
Balance Sheet Decomposition is not available for
Dyne Therapeutics Inc
Dyne Therapeutics Inc
Balance Sheet
Dyne Therapeutics Inc
Dyne Therapeutics Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
8
|
15
|
301
|
201
|
172
|
122
|
435
|
|
| Cash Equivalents |
8
|
15
|
301
|
201
|
172
|
122
|
435
|
|
| Short-Term Investments |
0
|
0
|
45
|
176
|
84
|
1
|
207
|
|
| Other Current Assets |
0
|
0
|
4
|
6
|
10
|
6
|
17
|
|
| Total Current Assets |
8
|
15
|
349
|
382
|
266
|
129
|
659
|
|
| PP&E Net |
0
|
2
|
2
|
41
|
38
|
33
|
30
|
|
| PP&E Gross |
0
|
2
|
2
|
41
|
38
|
33
|
30
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
2
|
4
|
5
|
7
|
|
| Other Long-Term Assets |
0
|
0
|
2
|
2
|
2
|
2
|
2
|
|
| Total Assets |
8
N/A
|
16
+98%
|
353
+2 054%
|
426
+20%
|
306
-28%
|
165
-46%
|
691
+319%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
1
|
3
|
4
|
5
|
23
|
7
|
|
| Accrued Liabilities |
0
|
1
|
8
|
25
|
23
|
28
|
36
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
2
|
11
|
29
|
28
|
51
|
42
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
3
|
0
|
0
|
29
|
26
|
23
|
19
|
|
| Total Liabilities |
4
N/A
|
2
-41%
|
11
+358%
|
58
+423%
|
54
-6%
|
74
+37%
|
61
-17%
|
|
| Equity | ||||||||
| Common Stock |
9
|
27
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
5
|
20
|
79
|
229
|
397
|
633
|
950
|
|
| Additional Paid In Capital |
0
|
6
|
422
|
597
|
650
|
724
|
1 580
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Equity |
4
N/A
|
14
+233%
|
342
+2 346%
|
368
+8%
|
252
-31%
|
91
-64%
|
630
+590%
|
|
| Total Liabilities & Equity |
8
N/A
|
16
+98%
|
353
+2 054%
|
426
+20%
|
306
-28%
|
165
-46%
|
691
+319%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
44
|
44
|
45
|
52
|
56
|
61
|
102
|
|
Switch to:
Switch to:
See Also
Discover More
